newsroom
PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing
Completes clinical trial-scale production of cGMP Cepharanthine-2HCL drug substance.
Anfield Energy Announces Appointment of Chairman
The Warrants were previously issued on May 12, 2022 in connection with a bought deal private placement offering of subscription receipts completed by the Company.
Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine Use Disorder and Oral Psilocybin Thin Film Strip Program
The Company is currently evaluating the use of oral psilocybin as a potential treatment for methamphetamine use disorder with the University of Wisconsin-Madison.
Anfield Energy Announces Listing of Warrants
The Warrants were previously issued on May 12, 2022 in connection with a bought deal private placement offering of subscription receipts completed by the Company.